These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18379532)

  • 1. The contribution of combined crystalloid and colloid osmosis to fluid and sodium management in peritoneal dialysis.
    Freida P; Wilkie M; Jenkins S; Dallas F; Issad B
    Kidney Int Suppl; 2008 Apr; (108):S102-11. PubMed ID: 18379532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of Crystalloid versus Colloid Osmosis across the Peritoneal Membrane.
    Morelle J; Sow A; Fustin CA; Fillée C; Garcia-Lopez E; Lindholm B; Goffin E; Vandemaele F; Rippe B; Öberg CM; Devuyst O
    J Am Soc Nephrol; 2018 Jul; 29(7):1875-1886. PubMed ID: 29844208
    [No Abstract]   [Full Text] [Related]  

  • 3. Peritoneal transport characteristics with glucose polymer based dialysate.
    Ho-dac-Pannekeet MM; Schouten N; Langendijk MJ; Hiralall JK; de Waart DR; Struijk DG; Krediet RT
    Kidney Int; 1996 Sep; 50(3):979-86. PubMed ID: 8872974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A combined crystalloid and colloid pd solution as a glucose-sparing strategy for volume control in high-transport apd patients: a prospective multicenter study.
    Freida P; Issad B; Dratwa M; Lobbedez T; Wu L; Leypoldt JK; Divino-Filho JC
    Perit Dial Int; 2009; 29(4):433-42. PubMed ID: 19602609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Icodextrin: a review of its use in peritoneal dialysis.
    Frampton JE; Plosker GL
    Drugs; 2003; 63(19):2079-105. PubMed ID: 12962523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of crystalloid (glucose) and colloid (icodextrin) osmotic agents markedly enhances peritoneal fluid and solute transport during the long PD dwell.
    Freida P; Galach M; Divino Filho JC; Werynski A; Lindholm B
    Perit Dial Int; 2007; 27(3):267-76. PubMed ID: 17468474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A preceding exchange with polyglucose versus glucose solution modifies peritoneal equilibration test results.
    Lilaj T; Dittrich E; Puttinger H; Schneider B; Haag-Weber M; Hörl WH; Vychytil A
    Am J Kidney Dis; 2001 Jul; 38(1):118-26. PubMed ID: 11431191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium removal and peritoneal dialysis modalities: no differences with optimal prescription of icodextrin.
    Fourtounas C; Dousdampanis P; Hardalias A; Vlachojannis JG
    Artif Organs; 2013 Jul; 37(7):E107-13. PubMed ID: 23461737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of volume overload with cycler-assisted versus continuous ambulatory peritoneal dialysis.
    Davison SN; Jhangri GS; Jindal K; Pannu N
    Clin J Am Soc Nephrol; 2009 Jun; 4(6):1044-50. PubMed ID: 19406971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic consequences of peritoneal dialysis.
    Burkart J
    Semin Dial; 2004; 17(6):498-504. PubMed ID: 15660581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Icodextrin degradation products in spent dialysate of CAPD patients and the rat, and its relation with dialysate osmolality.
    de Waart DR; Zweers MM; Struijk DG; Krediet RT
    Perit Dial Int; 2001; 21(3):269-74. PubMed ID: 11475342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between peritoneal permeability and ultrafiltration volume with icodextrin-based peritoneal dialysis solution.
    Moriishi M; Kawanishi H; Watanabe H; Tsuchiya S
    Adv Perit Dial; 2004; 20():166-9. PubMed ID: 15384820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal use of glucose polymer (icodextrin) in peritoneal dialysis.
    Mistry CD; Gokal R
    Perit Dial Int; 1996; 16 Suppl 1():S104-8. PubMed ID: 8728173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Icodextrin: overview of clinical experience.
    Peers E; Gokal R
    Perit Dial Int; 1997; 17(1):22-6. PubMed ID: 9068018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computer simulations of ultrafiltration profiles for an icodextrin-based peritoneal fluid in CAPD.
    Rippe B; Levin L
    Kidney Int; 2000 Jun; 57(6):2546-56. PubMed ID: 10844624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Peritoneal Dialysis.
    Mistry CD; Gokal R; Peers E
    Kidney Int; 1994 Aug; 46(2):496-503. PubMed ID: 7967363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-Polydispersity Glucose Polymers as Osmotic Agents for Peritoneal Dialysis.
    Leypoldt JK; Hoff CM; Akonur A; Holmes CJ
    Perit Dial Int; 2015; 35(4):428-35. PubMed ID: 24584616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ISPD recommendations for the evaluation of peritoneal membrane dysfunction in adults: Classification, measurement, interpretation and rationale for intervention.
    Morelle J; Stachowska-Pietka J; Öberg C; Gadola L; La Milia V; Yu Z; Lambie M; Mehrotra R; de Arteaga J; Davies S
    Perit Dial Int; 2021 Jul; 41(4):352-372. PubMed ID: 33563110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Icodextrin provides long dwell peritoneal dialysis and maintenance of intraperitoneal volume.
    Peers E; Gokal R
    Artif Organs; 1998 Jan; 22(1):8-12. PubMed ID: 9456219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Icodextrine peritoneal dialysis solution in clinical practice].
    Opatrná S
    Vnitr Lek; 2008 Dec; 54(12):1155-60. PubMed ID: 19140524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.